← Leaderboards
Christopher R Flowers
Emory University
$13,825,026
Attributed
$25,763,158
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.2M · FY2012–25$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,360,250 · 10
By mechanism
U01$23,432,499 · 2
P01$5,035,979 · 1
U54$3,699,386 · 5
K24$821,876 · 1
R21$370,510 · 1
Top collaborators
- James R Cerhan19 shared
- Lee Cooper3 shared
- Metin Nafi Gurcan3 shared
- Leandro C Cerchietti2 shared
- Jean L Koff1 shared
Most similar at Emory University
Same institution · by research overlap
- Francois J Villinger$61,853,654
- Lee Cooper$6,337,159
- Daniel Huddleston$962,820
- Mary R Galinski$18,988,233
- Kevin Ward$36,990,267
Others in their field
Top investigators on “S Lymphoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$171,980,034
- Richard L Schilsky · University Of Chicago$120,036,663
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$113,682,224
- Ronald T Mitsuyasu · University Of California Los Angeles$103,553,444
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Charles A Coltman · Southwest Oncology Group$55,198,633
Research focus
S LymphomaLymphomaNon-Hodgkin&AposResourcesTumorMalignant NeoplasmsGeneticPathologyDiagnosisCohort StudiesClinical DataResearch PersonnelEpidemiologyAfrican AmericanResearch Project GrantsPatient PopulationClinical ResearchRelapseNewly DiagnosedSurvivorshipFollow-UpParticipantPatient Outcomes AssessmentsDisease Progression
Grant awards (37)
Lymphoma Outcomes SPORE$2,561,113
U54 · FY2025 · CA · contact PI
Epigenetic basis and therapeutic targeting of the unique lymphoma immunological niche$2,474,764
P01 · FY2025 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$1,976,587
U01 · FY2025 · CA
Core A: Administrative Core$284,569
U54 · FY2025 · CA · contact PI
Project 1: Precision targeting of therapeutic vulnerabilities specific to African American lymphoma patients$284,568
U54 · FY2025 · CA · contact PI
Project 2: Translating Genomics to Practice to Overcome Disparities in Diffuse Large B-Cell Lymphoma (DLBCL)$284,568
U54 · FY2025 · CA · contact PI
Career Enhancement Program$284,568
U54 · FY2025 · CA · contact PI
Epigenetic basis and therapeutic targeting of the unique lymphoma immunological niche$2,561,215
P01 · FY2024 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$1,876,237
U01 · FY2024 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (Diversity Supplement - Mazie Tsang)$127,071
U01 · FY2024 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (Diversity Supplement - Alexis Romero)$20,848
U01 · FY2024 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$1,938,063
U01 · FY2023 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$1,938,064
U01 · FY2022 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (Supplement)$195,572
U01 · FY2022 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$2,008,420
U01 · FY2021 · CA
Informatics Tools for Quantitative Digital Pathology Profiling and Integrated Prognostic Modeling$437,968
U01 · FY2021 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$486,178
U01 · FY2020 · CA
Mentored Patient Oriented Research in Lymphoma$164,375
K24 · FY2020 · CA · contact PI
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$2,177,529
U01 · FY2019 · CA
Informatics Tools for Quantitative Digital Pathology Profiling and Integrated Prognostic Modeling$425,457
U01 · FY2019 · CA
Mentored Patient Oriented Research in Lymphoma$147,817
K24 · FY2019 · CA · contact PI
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$67,878
U01 · FY2019 · CA
Mentored Patient Oriented Research in Lymphoma$16,559
K24 · FY2019 · CA · contact PI
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$2,246,690
U01 · FY2018 · CA
Informatics Tools for Quantitative Digital Pathology Profiling and Integrated Prognostic Modeling$467,872
U01 · FY2018 · CA
Mentored Patient Oriented Research in Lymphoma$164,375
K24 · FY2018 · CA · contact PI
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$61,414
U01 · FY2018 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$2,248,270
U01 · FY2017 · CA
Mentored Patient Oriented Research in Lymphoma$164,375
K24 · FY2017 · CA · contact PI
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$14,960
U01 · FY2017 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$2,251,244
U01 · FY2016 · CA
Mentored Patient Oriented Research in Lymphoma$164,375
K24 · FY2016 · CA · contact PI
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$45,332
U01 · FY2016 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$14,960
U01 · FY2016 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study$2,405,885
U01 · FY2015 · CA
Biological Variants Underlying Racial Differences in Lymphoma$190,284
R21 · FY2013 · CA · contact PI
Biological Variants Underlying Racial Differences in Lymphoma$180,226
R21 · FY2012 · CA · contact PI